• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY EVO/EVO + VISIAN IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY EVO/EVO + VISIAN IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS Back to Search Results
Model Number VTICM5 12.6 (-11.5/ 2.5)
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/09/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H11: manufacturer narrative: secondary surgical intervention to remove/replace/reposition the lens is identified in the labeling as a known potential adverse event following icl implantation.H6, type of investigation code: 4110, lens work order search-no similar complaint event(s) within associated lots were found.Claim# (b)(4).
 
Event or Problem Description
A facility representative reported that following an implantable collamer lens (icl) implantation procedure, the patient experienced lens rotation not associated with low vault and blurred vision.In a separate surgery the lens was explanted.On the same day separate surgery a longer length was implanted and the problem was resolved.The cause of the event was reported as unknown.
 
Additional Manufacturer Narrative
Device evaluation: h3 - type of investigation code (b): 10- device evaluation: the lens was returned dry in a microcentrifuge tube with liquid and residue/debris on product.Visual inspection found no visible damage to lens.Dimensional inspection found the lens to be within specifications.Corrected data: b5.- a facility representative reported that following an implantable collamer lens (icl) implantation procedure, the patient experienced lens rotation not associated with low vault and blurred vision.In a separate surgery the lens was explanted.On the same day separate surgery a longer length was implanted.The cause of the event was reported as unknown.It has been noted that the surgeon selected a different lens size than that initially suggested by the icl calculation software.There are multiple medical device reports associated with this patient.This report is 1 of 2 total reports.Based on the information provided, the risk assessment for our product, and our experience, we have determined the cause or contribution to the reported issue is not indicative of a manufacturing related issue or product deficiency.Claim# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVO/EVO + VISIAN IMPLANTABLE COLLAMER LENS (ICL)
Common Device Name
PHAKIC TORIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia 91016
Manufacturer (Section G)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
joselene enriquez
1911 walker avenue
monrovia, CA 91016
MDR Report Key24641407
Report Number2023826-2026-00469
Device Sequence Number10207251
Product Code QCB
Combination Product (Y/N)N
Initial Reporter CountryMY
PMA/510(K) Number
P030016
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Device Explanted Year2026
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative,Distributor
Type of Report Initial,Followup
Report Date (Section B) 03/19/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberVTICM5 12.6 (-11.5/ 2.5)
Device Catalogue NumberVTICM5 12.6
Device Lot NumberN/A
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/17/2026
Supplement Date Received by Manufacturer06/18/2026
Initial Report FDA Received Date03/19/2026
Supplement Report FDA Received Date06/23/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/17/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age29 YR
Patient SexMale
-
-